Literature DB >> 24511094

Endogenous retroviruses and the development of cancer.

George Kassiotis1.   

Abstract

Mammalian genomes include a considerable number of endogenous retroviruses (ERVs), relics of ancestral infectious retroviruses, whose proviruses have invaded the germ-line. The documented ability of infectious retroviruses to cause cancer has greatly contributed to the discovery of ERVs. It also reinforced the concept that ERVs are causative agents of many cancers, a notion that historically has not always stood up to experimental scrutiny. The recent greater appreciation of the complexity of ERV biology and the identification of dedicated host mechanisms controlling ERV activity have revealed novel interactions between ERVs and their hosts, with the potential to cause or contribute to disease. In this review, the involvement of ERVs in cancer initiation and progression is discussed, as well as their contribution to our understanding of the process of transformation and to the invention of innovative preventive and therapeutic cancer treatments.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24511094      PMCID: PMC3925786          DOI: 10.4049/jimmunol.1302972

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  90 in total

1.  Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression.

Authors:  E Oricchio; I Sciamanna; R Beraldi; G V Tolstonog; G G Schumann; C Spadafora
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

Review 2.  Endogenous retroviruses: acquisition, amplification and taming of genome invaders.

Authors:  Marie Dewannieux; Thierry Heidmann
Journal:  Curr Opin Virol       Date:  2013-09-01       Impact factor: 7.090

Review 3.  Classification and nomenclature of endogenous retroviral sequences (ERVs): problems and recommendations.

Authors:  Jonas Blomberg; Farid Benachenhou; Vidar Blikstad; Göran Sperber; Jens Mayer
Journal:  Gene       Date:  2009-06-18       Impact factor: 3.688

4.  Brief communication: C-type particles in normal human placentas.

Authors:  S S Kalter; R J Helmke; R L Heberling; M Panigel; A K Fowler; J E Strickland; A Hellman
Journal:  J Natl Cancer Inst       Date:  1973-04       Impact factor: 13.506

5.  Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity.

Authors:  Robert Belshaw; Anna L A Dawson; John Woolven-Allen; Joanna Redding; Austin Burt; Michael Tristem
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Role of endogenous retroviruses as mutagens: the hairless mutation of mice.

Authors:  J P Stoye; S Fenner; G E Greenoak; C Moran; J M Coffin
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

7.  Tumor cells expressing a retroviral envelope escape immune rejection in vivo.

Authors:  M Mangeney; T Heidmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus.

Authors:  Toshio Naito; Hitoshi Ogasawara; Hiroshi Kaneko; Takashi Hishikawa; Iwao Sekigawa; Hiroshi Hashimoto; Naoki Maruyama
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

Review 9.  Insertional oncogenesis by non-acute retroviruses: implications for gene therapy.

Authors:  Hung Fan; Chassidy Johnson
Journal:  Viruses       Date:  2011-04-15       Impact factor: 5.048

10.  An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a.

Authors:  Peter J R Ebert; Shan Jiang; Jianming Xie; Qi-Jing Li; Mark M Davis
Journal:  Nat Immunol       Date:  2009-10-04       Impact factor: 25.606

View more
  73 in total

Review 1.  Immune responses to endogenous retroelements: taking the bad with the good.

Authors:  George Kassiotis; Jonathan P Stoye
Journal:  Nat Rev Immunol       Date:  2016-04       Impact factor: 53.106

Review 2.  CTRL+INSERT: retrotransposons and their contribution to regulation and innovation of the transcriptome.

Authors:  Jonathan Göke; Huck Hui Ng
Journal:  EMBO Rep       Date:  2016-07-11       Impact factor: 8.807

Review 3.  p53 in the game of transposons.

Authors:  Annika Wylie; Amanda E Jones; John M Abrams
Journal:  Bioessays       Date:  2016-09-19       Impact factor: 4.345

4.  Comprehensive Characterization of the Human Endogenous Retrovirus HERV-K(HML-6) Group: Overview of Structure, Phylogeny, and Contribution to the Human Genome.

Authors:  Maria Paola Pisano; Nicole Grandi; Marta Cadeddu; Jonas Blomberg; Enzo Tramontano
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

5.  Antibody-based Delivery of TNF to the Tumor Neovasculature Potentiates the Therapeutic Activity of a Peptide Anticancer Vaccine.

Authors:  Philipp Probst; Marco Stringhini; Danilo Ritz; Tim Fugmann; Dario Neri
Journal:  Clin Cancer Res       Date:  2018-10-16       Impact factor: 12.531

6.  Unexpected Discovery and Expression of Amphibian Class II Endogenous Retroviruses.

Authors:  Mingyue Chen; Xiaoxia Guo; Lei Zhang
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

Review 7.  Regulatory activities of transposable elements: from conflicts to benefits.

Authors:  Edward B Chuong; Nels C Elde; Cédric Feschotte
Journal:  Nat Rev Genet       Date:  2016-11-21       Impact factor: 53.242

Review 8.  Interplay between viruses and bacterial microbiota in cancer development.

Authors:  Dariia Vyshenska; Khiem C Lam; Natalia Shulzhenko; Andrey Morgun
Journal:  Semin Immunol       Date:  2017-06-09       Impact factor: 11.130

Review 9.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

10.  Evidence for the persistence of an active endogenous retrovirus (ERVE) in humans.

Authors:  Horacio Naveira; Xabier Bello; José Luis Abal-Fabeiro; Xulio Maside
Journal:  Genetica       Date:  2014-09-06       Impact factor: 1.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.